News

As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a ...
The University of Hong Kong (HKU) has launched a clinical trial for a gene-related therapy aimed at treating chronic ...
Hepatitis A infection requires understanding symptoms, prevention strategies, and recovery management for effective treatment and lifelong immunity development.
Hepatitis B is relatively frequent in the Bouaké military region, with a prevalence of 5.23%. It predominantly affects ...
Artenie and colleagues presented the first global, regional and national estimates of hepatitis C virus incidence among ...
The University of Hong Kong’s Faculty of Medicine said on Thursday that one of its 41 drugs under clinical trials for Hepatitis B may provide a cure ...
Barwon Health is using a new outreach program to try to identify people living with undiagnosed hepatitis C. Hepatitis C is a bloodborne virus that affects the liver and can cause chronic liver ...
China has made significant strides in controlling hepatitis B virus (HBV) infection over the past three decades, reducing the prevalence of hepatitis ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
A large-scale study tracing human disease history back 37,000 years has identified harmful bacteria, viruses and parasites ...
Researchers in gastroenterology and hepatology at HKUMed are pioneering gene-related therapy for chronic hepatitis B infection, potentially enabling ...
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical ...